Massive global study aims to unlock secrets of rare heart and nerve disease
NCT ID NCT04561518
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This observational study will follow 1,500 people with ATTR amyloidosis, a rare disease that damages the heart and nerves, for many years. Researchers will track how the disease progresses, how patients are treated in real-world settings, and the safety of two approved drugs, patisiran and vutrisiran. The goal is to better understand the condition and improve patient care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could provide a clearer picture of how ATTR amyloidosis progresses and how well current treatments work in everyday life, helping doctors manage the disease better.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may take years and might not lead to immediate changes in care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN-MEDIATED AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGLa Jolla, California, 92037, United States
-
Clinical Trial Site
RECRUITINGLos Angeles, California, 90095, United States
-
Clinical Trial Site
RECRUITINGJacksonville, Florida, 32224, United States
-
Clinical Trial Site
RECRUITINGIowa City, Iowa, 52242, United States
-
Clinical Trial Site
RECRUITINGKansas City, Kansas, 66160, United States
-
Clinical Trial Site
RECRUITINGBaltimore, Maryland, 21224, United States
-
Clinical Trial Site
COMPLETEDBoston, Massachusetts, 02127, United States
-
Clinical Trial Site
RECRUITINGNew York, New York, 10034, United States
-
Clinical Trial Site
RECRUITINGDurham, North Carolina, 27710, United States
-
Clinical Trial Site
RECRUITINGColumbus, Ohio, 43210, United States
-
Clinical Trial Site
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Clinical Trial Site
RECRUITINGAustin, Texas, 78756, United States
-
Clinical Trial Site
RECRUITINGHouston, Texas, 77030, United States
-
Clinical Trial Site
RECRUITINGSalvador, Brazil
-
Clinical Trial Site
RECRUITINGSão Paulo, Brazil
-
Clinical Trial Site
RECRUITINGSofia, Bulgaria
-
Clinical Trial Site
RECRUITINGAarhus, Denmark
-
Clinical Trial Site
COMPLETEDCopenhagen, Denmark
-
Clinical Trial Site
RECRUITINGBordeaux, France
-
Clinical Trial Site
RECRUITINGBron, France
-
Clinical Trial Site
RECRUITINGCréteil, France
-
Clinical Trial Site
RECRUITINGLe Kremlin-Bicêtre, France
-
Clinical Trial Site
RECRUITINGMarseille, France
-
Clinical Trial Site
RECRUITINGBerlin, Germany
-
Clinical Trial Site
RECRUITINGGiessen, Germany
-
Clinical Trial Site
RECRUITINGHanover, Germany
-
Clinical Trial Site
RECRUITINGJerusalem, Israel
-
Clinical Trial Site
RECRUITINGRamat Gan, Israel
-
Clinical Trial Site
RECRUITINGMilan, Italy
-
Clinical Trial Site
RECRUITINGNaples, Italy
-
Clinical Trial Site
RECRUITINGPalermo, Italy
-
Clinical Trial Site
RECRUITINGRoma, Italy
-
Clinical Trial Site
RECRUITINGGroningen, Netherlands
-
Clinical Trial Site
RECRUITINGLisbon, Portugal
-
Clinical Trial Site
RECRUITINGPorto, Portugal
-
Clinical Trial Site
RECRUITINGBarcelona, Spain
-
Clinical Trial Site
RECRUITINGMadrid, Spain
-
Clinical Trial Site
RECRUITINGPalma, Spain
-
Clinical Trial Site
RECRUITINGNew Taipei City, Taiwan
-
Clinical Trial Site
RECRUITINGTaipei, Taiwan